Arcadia Biosciences, Inc. Leases Disclosure
Note 15. Leases
Operating Leases
As of December 31, 2025, the Company leases office space in Dallas, TX. Leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these short-term leases on a straight-line basis.
The Company’s lease agreements do not contain any material variable lease payments, material residual value guarantees or material restrictive covenants. Leases consisted of the following (in thousands):
Leases |
|
Classification |
|
December 31, 2025 |
|
|
December 31, 2024 |
|
||
Assets |
|
|
|
|
|
|
|
|
||
Operating lease assets |
|
Right of use asset |
|
$ |
— |
|
|
$ |
137 |
|
Total leased assets |
|
|
|
$ |
— |
|
|
$ |
137 |
|
Liabilities |
|
|
|
|
|
|
|
|
||
Current - Operating |
|
Operating lease liability - current |
|
$ |
— |
|
|
$ |
155 |
|
Total leased liabilities |
|
|
|
$ |
— |
|
|
$ |
155 |
|
Lease Cost |
|
Classification |
|
For the |
|
|
For the |
|
||
Operating lease cost |
|
SG&A and R&D Expenses |
|
$ |
139 |
|
|
$ |
850 |
|
Short term lease cost |
|
SG&A and R&D Expenses |
|
|
4 |
|
|
|
13 |
|
Sublease income (1) |
|
SG&A and R&D Expenses |
|
|
(143 |
) |
|
|
(547 |
) |
Net lease cost |
|
|
|
$ |
— |
|
|
$ |
316 |
|
(1) Sublease income is recorded as a reduction to lease expense.
Lease Term and Discount Rate |
|
December 31, 2025 |
|
|
December 31, 2024 |
|
||
Weighted-average remaining |
|
|
|
|
|
0.6 |
|
|
Weighted-average discount rate |
|
|
0.0 |
% |
|
|
6.5 |
% |
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 26, 2026 | Showing above |
| 2024 | Mar 25, 2025 | |
| 2023 | Mar 28, 2024 | |
| 2022 | Mar 30, 2023 | |
| 2021 | Mar 31, 2022 | |
About Leases Disclosures
Lease disclosures under ASC 842 provide a comprehensive view of a company's leased asset portfolio, including the split between operating and finance leases, discount rates used to present-value future payments, and the maturity schedule of lease obligations. This section reveals a significant source of off-balance-sheet commitments that were largely hidden before the current standard.
Key signals: the weighted-average discount rate affects the size of recorded lease liabilities — a higher rate reduces the reported obligation, so compare the chosen rate against the company's incremental borrowing rate. The operating versus finance lease mix affects both EBITDA and operating income presentation. Watch the maturity table for concentration risk: large payment cliffs in specific years may create cash flow pressure. Variable lease payments excluded from the liability measurement represent real obligations that do not appear on the balance sheet. Compare total lease costs against prior-year operating lease expense to assess the true economic burden.